Clinical Trials Logo
  1. Home
  2. Mental Retardation
  3. NCT00597948

Healthy Lifestyles for People With Intellectual Disabilities — HLID  

Mental Retardation Clinical Trial

Official title:
Efficacy of a Health Intervention for People With Intellectual Disabilities

Clinical Trial Summary

Relatively few health promotion and disease prevention programs have included or targeted people with disabilities, and even fewer have focused on individuals with intellectual disabilities.

The long-term objectives of the Healthy Lifestyles for People with Intellectual Disabilities Study (HLID) are to increase the health of persons with intellectual disabilities by establishing the efficacy of a health promotion program and promoting its adoption. The HLID Study is based in the Center on Community Accessibility (CCA) at Oregon Health & Science University. The mission of CCA is to increase the health and health-related quality of life of persons with disabilities.

A pilot study conducted by CCA has established the effectiveness of the Healthy Lifestyles (HL) intervention among a cross-disability population in increasing health behavior adoption. The specific aim of the HLID Study is to test the efficacy of the HL program specifically with adults with intellectual disabilities.

The HLID Study uses a randomized control study design. The HL intervention will be administered to 75 adults and will compare results to those of an additional 75 adults who receive no intervention. Measurement will include anthropometric assessments to measure impacts on overweight and obesity, as well as self-report measures of healthy behaviors, health status, health care utilization, and secondary conditions. Results will be shared with research participants, presented through professional conferences and newsletters, and published in peer-reviewed journals with the assistance of community partners.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00597948
Study type Interventional
Source Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contact
Status Completed
Phase N/A
Start date April 2007
Completion date March 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT02791321 - Fragility Assessment in Adults With ADHD and Mental Retardation N/A
Recruiting NCT01908400 - Safety and Efficacy of BMMNCin Patients With Mental Retardation Phase 1/Phase 2
Withdrawn NCT02245724 - Stem Cell Therapy in Mental Retardation Phase 1
Completed NCT00156221 - MR Scanning of Very Young Children With Severe Developmental Disorders N/A
Recruiting NCT00491478 - Repetitive Behavior Disorders in People With Severe Mental Retardation Phase 3
Terminated NCT02797418 - "Cognitus & Moi": a New Cognitive Remediation Tool N/A
Completed NCT00758108 - Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Completed NCT01430845 - Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Not yet recruiting NCT02214745 - Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community N/A
Active, not recruiting NCT00552526 - Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy Phase 4
Completed NCT02943304 - Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Completed NCT00491894 - Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions Phase 3
Completed NCT01291238 - School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability. N/A
Completed NCT01456910 - Resistance Training Program, Labor Inclusion, Intellectual Disability N/A
Completed NCT00065273 - Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay Phase 3
Active, not recruiting NCT00065936 - Self-Injury: Diagnosis and Treatment Phase 3
Completed NCT00506259 - Treatment Strategies for Children With Smith-Magenis Syndrome Phase 1
Not yet recruiting NCT05442229 - A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
Active, not recruiting NCT06370793 - Ningbo Severe Mental Disorders Cohort
Completed NCT01517048 - Brain-Derived Neurotrophic Factor in Obesity and Brain Function